New delivery system, designed for Abbott's Proclaim™ DRG neurostimulation system, promotes efficient placement of neurostimulation leads on the dorsal root ganglion (DRG) Abbott's system is the only ...

Abbott announced the launch of its neuromodulation business’ next-generation delivery system, which will be used to streamline the implantation process for electrodes used as part of its Proclaim DRG ...

Abbott has launched a “next-generation” delivery system to streamline the electrode implantation process for its Proclaim DRG neurostimulation system. This advancement aims to improve treatments for ...

The Proclaim DRG neurostimulation device. [Image courtesy of Abbott] Abbott (NYSE: ABT) + announced today that it launched a next-generation delivery system for its neuromodulation business.

Credit: Sundry Photography / Shutterstock. Abbott has launched a “next-generation” delivery system to streamline the electrode implantation process for its Proclaim DRG neurostimulation system. This ...

Juliane Ray, Vice President, Product Management, Medtech, Life Sciences & Healthcare, Clarivate, said: "DRG Commercial Analytics 360 was purpose-built to help medtech companies translate real ...

In fact, you can now buy “vagal reset” gadgets to practice what’s broadly referred to as neurostimulation at home – Instagram and Tiktok are awash with ads for them. And for more intense ...

BANGI: The first phase of Malaysia's national Diagnosis-Related Group (DRG) system, focusing on minor illnesses in hospitals, is expected to be implemented by the end of 2025, Health Minister ...